Litcius/Paper detail

Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease

Zhipeng Song, Rui Gao, Bo Yan

2020Reviews in Cardiovascular Medicine40 citationsDOIOpen Access PDF

Abstract

Cardiovascular disease is still the main cause of morbidity and mortality worldwide. Currently, the frontier of research into cardiovascular disease is the field of non-coding RNA. In this review, information was collected on the use of micro-RNAs as non-invasive biomarkers and their role in pathophysiological processes and therapeutic applications. In the case of microRNA-1 and microRNA-133, the roles and regulatory mechanisms of them are reviewed for arrhythmia, myocardial infarction, diabetic cardiomyopathy, myocardial hypertrophy, cardiomyocyte differentiation, and cell reprogramming. It was observed that microRNA-1 and microRNA-133 do not exist independently, but are two co-transcriptional and cooperative regulatory factors. They have diagnostic value as biomarkers, but also have the potential as therapeutic targets such as for antiarrhythmia and cardiac reprogramming.

Topics & Concepts

microRNAMedicineReprogrammingDiseaseMyocardial infarctionBioinformaticsCardiologyInternal medicineCellBiologyGeneGeneticsMicroRNA in disease regulationCircular RNAs in diseasesFuel Cells and Related Materials
Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease | Litcius